Issue |
E3S Web Conf.
Volume 511, 2024
International Conference on “Advanced Materials for Green Chemistry and Sustainable Environment” (AMGSE-2024)
|
|
---|---|---|
Article Number | 01002 | |
Number of page(s) | 13 | |
DOI | https://doi.org/10.1051/e3sconf/202451101002 | |
Published online | 10 April 2024 |
Revolutionizing Healthcare through Applications and Challenges of Nanomaterials in Targeted Drug Delivery and Therapeutics
1 Chitkara Center for Research and Development, Chitkara University, Himachal Pradesh, 174103, India
2 Centre of Research Impact and Outcome, Chitkara University, Rajpura - 140401, Punjab, India
3 Department of Mechanical Engineering, GLA University, Mathura - 281406, India
4 Department of Mechanical Engineering, Graphic Era Deemed to be University, Dehradun, Uttarakhand
5 Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamilnadu
6 Lloyd Institute of Engineering & Technology, Greater Noida
7 Lloyd Law College, Greater Noida
* Corresponding author: anuragshri76@gmail.com
This research investigates the cutting edge of healthcare advancement through the applications and challenges of nanomaterials focused on sedate conveyance and therapeutics. Gold nanoparticles (AuNPs) and liposomes were synthesized, characterized, and utilized as carriers for doxorubicin, illustrating remarkable medicate stacking capacities of 4.5% and 80.2%, individually. The discharge energy uncovered a Higuchi demonstration for AuNPs and first-order energy for liposomes, exhibiting custom-fitted medicate discharge profiles. In vitro studies illustrated critical cytotoxicity, with an IC50 of 12.3 µM for AuNPs in A549 cells and 8.7 µM for liposomes in MCF-7 cells. Cellular take-up rates of 35.6% and 50.2% advance asserted their adequacy. Moving to in vivo studies, the circulation half-life of AuNPs was 6.2 hours, whereas liposomes displayed a longer half-life of 8.5 hours. Bio distribution ponders illustrated particular aggregation within the tumor, coming to 4.8% ID/g for AuNPs and 6.2% ID/g for liposomes. Helpful results included tumor measure decrease and by and large survival rates of 75.4% for AuNPs and 82.7% for liposomes. Comparison with related works highlighted the competitive execution of the created nanomaterials, emphasizing their potential in progressing exactness medication. This research contributes to the advancing scene of nanomedicine, emphasizing personalized and maintainable healthcare arrangements.
Key words: Targeted Drug Delivery / Nanomaterials / Liposomes / Gold Nanoparticles / Therapeutics
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.